Oligomeric proanthocyanidins

phytochemicalproanthocyanidin

At a glance

Best for
people with chronic venous insufficiency or leg-vein symptoms
Typical dose
100–300 mg/day standardized extract
Time to effect
Weeks
Main caution
may add to blood-thinning and blood-pressure-lowering effects
Evidence strength: Moderate for venous insufficiency; biomarker-level for blood pressure

What is it

Oligomeric proanthocyanidins (OPCs) are a class of flavonoid antioxidants made of linked catechin/epicatechin units, found concentrated in grape seed, pine bark (Pycnogenol), and other plants. They are marketed for vascular health, antioxidant support, and skin. The best human evidence is for chronic venous insufficiency and modest blood-pressure effects, much of it from specific branded extracts.

Is it worth it for you?

Worth considering if…

  • You have chronic venous insufficiency, leg heaviness or swelling
  • You want a standardized grape-seed or pine-bark extract with some trial support
  • You will trial it for several weeks and track leg symptoms

Probably skip if…

  • You expect cardiovascular event prevention rather than symptom/biomarker change
  • You take anticoagulants without medical oversight
  • You want proven anti-aging or anti-cancer effects

Evidence at a glance

GoalEvidenceEffectBest fitTime
chronic venous insufficiencyLimitedModestadults with chronic venous insufficiency, leg heaviness, or edemaWeeks
blood pressureLimitedSmall (~a few mmHg)adults with elevated or high-normal blood pressureWeeks

Evidence for 2 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

chronic venous insufficiency

Supplement benefit
Limited

Multiple randomized trials of grape seed and pine bark OPC extracts report reduced leg edema, heaviness, and related symptoms of chronic venous insufficiency versus placebo. Effects are modest and trials vary in extract and quality, but the direction of benefit is fairly consistent for this use.

Effect size: Modest
Time to effect: Weeks
Best fit: adults with chronic venous insufficiency, leg heaviness, or edema

Bottom line: Standardized OPC extracts give modest, fairly consistent relief of chronic venous insufficiency symptoms.

blood pressure

Biomarker support
Limited

Meta-analyses of grape seed extract trials show a small reduction in systolic (and sometimes diastolic) blood pressure, on the order of a few mmHg, more apparent in younger or metabolically at-risk subjects. This is a biomarker change; trials are short and do not show reductions in cardiovascular events.

Effect size: Small (~a few mmHg)
Time to effect: Weeks
Best fit: adults with elevated or high-normal blood pressure
Less likely: people with well-controlled normal blood pressure

Bottom line: May lower blood pressure by a few mmHg, but this is a biomarker effect, not proven outcome benefit.

Evidence is mixed

Average reductions are small and not seen consistently across all subgroups or trials.

How to take it

Typical dose
100–300 mg/day of a standardized OPC extract
Higher studied dose
Up to ~300–360 mg/day in some venous and blood-pressure studies
Timing
With meals
With food
With food
Split dosing
Can be split into two daily doses
How long to try
Trial 6–12 weeks for venous symptoms or blood pressure

What to track

  • Leg swelling/heaviness
  • Blood pressure
  • Any easy bruising

Safety

Common side effects

Generally well tolerated, Occasional headache, nausea, or dizziness

Who should avoid it

  • People on anticoagulants without medical advice
  • People scheduled for surgery (stop beforehand)

Pregnancy & breastfeeding

Insufficient safety data for concentrated extracts in pregnancy or breastfeeding; avoid unless advised.

Interactions

Anticoagulants/antiplatelets (e.g. warfarin, aspirin)Moderate

OPCs may have mild antiplatelet activity, increasing bleeding risk.

Antihypertensive drugsMinor

Possible additive blood-pressure lowering.

Choosing a product

Look for

  • Standardized OPC/proanthocyanidin content (e.g. % polyphenols)
  • Named source (grape seed, pine bark) and extract
  • Third-party testing

Be skeptical of

  • Anti-cancer or anti-aging cure claims
  • 'Detox' or megadose antioxidant marketing
  • Claims of preventing heart attacks or strokes

References by claim

chronic venous insufficiency

  • Arcangeli et al., 2000PubMed (2000) link
  • Petrassi et al., 2000PubMed (2000) link

blood pressure

  • Odai et al., 2019PMC (2019) link

Track Oligomeric proanthocyanidins with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.